Bulletin
Investor Alert

Topics

Implants

7:50 a.m. Feb. 17, 2021 - MarketWatch.com
Rush Limbaugh, ‘voice of American conservatism,’ has died at 70Rush Limbaugh, the talk radio host who ripped into liberals, foretold the rise of Donald Trump and laid waste to political correctness with a merry brand of malice that made him one of the most powerful voices on the American right, died Wednesday. He was 70.
2:37 a.m. Feb. 1, 2021 - Barrons.com
What We Learned From a Week of Big Earnings Amid GameStop Chaos More than 115 S&P 500 companies reported results last week. Tech and financial earnings rose while industrial earnings remain depressed.
9:02 a.m. Jan. 31, 2021 - By Quentin Fottrell
My sister is a single mother and thinks ‘squatter rights’ is the way to secure housing in the pandemic. What can I do? ‘She has been better with her money the last three months, but she has been very irresponsible in her spending the last few years — paying for breast implants, for example’‘She has been better with her money the last three months, but she has been very irresponsible in her spending the last few years — paying for breast implants, for example.’
11:59 p.m. Jan. 26, 2021 - MarketWatch.com
Could you be at risk of health problems from some dental fillings?Several groups, from pregnant women to people with neurological diseases are at higher risk from the metal in their mouth.
11:53 a.m. Jan. 26, 2021 - By Andrew Keshner
What can I do now that I’ve had my COVID-19 vaccine and my mom put me on her house’s deed and my brother wants halfTuesday’s Personal Finance Stories.
6:24 a.m. Jan. 19, 2021 - Barrons.com
Brain, Spine Stimulation Devices Are a Post-Pandemic Winner, Says Raymond James The equipment, made by companies such as Medtronic and Abbott Laboratories, offers an alternative to drugs for pain relief.
7:30 a.m. Jan. 8, 2021 - Barrons.com
2020 Was a Bad Year for Ransomware. 2021 Will Be Worse. Holding data hostage has become a lucrative criminal pursuit. It's not going away any time soon.
7:30 a.m. Nov. 23, 2020 - Barrons.com
Investors, Put the Rest of the World on Your Radar The U.S. trounced foreign markets in the past 10 years, but now it’s time to start shopping abroad. Twenty stock picks from our international roundtable
11:32 a.m. Nov. 16, 2020 - By Claudia Assis
SmileDirectClub narrows Q3 loss, sees 'broader acceptance' of teledentistrySmileDirectClub Inc. shares rose in the extended session Monday after the teledentistry company reported a narrower-than-expected quarterly loss and sales that were above Wall Street's expectations.
9:37 a.m. Oct. 15, 2020 - By Clarissa Sebag-Montefiore
Good Company: Eyewear Brand Article One’s Focus On Slow, Sustainable GrowthThe family-owned maker of sporty specs donates to causes at home and abroad
2:05 a.m. Oct. 12, 2020 - Barrons.com
Cannabis Use Is on the Rise. Where to Invest Now. Jason Wild’s JW Asset Management made prescient bets on specialty pharma and cannabis companies. What he likes now
5:36 a.m. Sept. 1, 2020 - Barrons.com
Global Eyewear Makers Bounce Back From the Coronavirus. Will It Last? Sales of some eyecare makers are nearly back to prepandemic levels, as the summer started looking up for the sector, say Bryan Garnier analysts.
4:29 a.m. Aug. 25, 2020 - Barrons.com
Medtronic Says It Is Recovering From Covid Shock Medtronic earnings were cut in half but they were better than expected.
1:58 p.m. May 23, 2020 - Barrons.com
America’s Small Businesses Are Sputtering Explore how the pandemic’s impact on small business is playing out, and how small businesses’ struggles will affect the broader economy and financial markets.
11:30 p.m. May 6, 2020 - Barrons.com
3 European Stocks That Should Survive the Pandemic Abcam, Sonova Holdings, and Avon Rubber are companies in a range sectors with strong balance sheets, the ability to use technology to build scale, and are benefiting from government spending.
1:22 a.m. April 17, 2020 - By Jaimy Lee
Johnson & Johnson execs offer upbeat view of second-half recovery from COVID-19 pandemic Here’s how Johnson & Johnson expects the pandemic to impact its 2020 performance: first quarter (initial impact), second quarter (significant impact), third quarter (stabilization), and fourth quarter (recovery)Johnson & Johnson executives had a surprisingly rosy take about an economic recovery in the second half of the year even as the COVID-19 pandemic cratered the company’s $25 billion medical device business in the first quarter of 2020.
6:35 a.m. April 11, 2020 - By Philip van Doorn
Three stocks to buy during the coronavirus crash — besides the usual suspects Michael Kagan of ClearBridge Investments outlines quality retail, medical and packaging companiesMichael Kagan of ClearBridge Investments outlines quality retail, medical and packaging companies.
11:00 a.m. March 26, 2020 - Barrons.com
The Lieber Institute is Forging a Brighter Future for People With Mental Disorders The Baltimore-based organization is a pioneer in the study of environmental brain diseases
8:51 a.m. March 5, 2020 - Associated Press
FDA bans electrical shock devices used on mentally disabled patients The announcement follows years of pressure from mental health experts who say the treatment is outdated, ineffective and unethicalThe announcement follows years of pressure from mental health experts who say the treatment is outdated, ineffective and unethical.
7:12 a.m. March 3, 2020 - By Jaimy Lee
Medical device makers hurt as coronavirus slows or halts elective surgeries in China Boston Scientific, Medtronic and Smith & Nephew said that delays in elective medical procedures in China will negatively impact their financial performance for the quarterSeveral of the world’s largest medical device makers warned investors that the COVID-19 outbreak has delayed and in some cases halted elective medical procedures — and that will likely cut into their earnings for the quarter.
Browse topics:

Filter results by

Location

Us (6)

Asia Pacific (1)

China (1)

Link to MarketWatch's Slice.